WHO ICTRP trial
Sequential Therapy versus Quadruple Therapy for H.pylori Eradication in Iran
IRCT201103183836N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201103183836N1 |
|---|---|
| Public title | Sequential Therapy versus Quadruple Therapy for H.pylori Eradication in Iran |
| Scientific title | Sequential Therapy versus Quadruple Therapy for H.pylori Eradication in Iran |
| Primary sponsor | Jundishapour Ahvaz Uuniversity of Medical Science |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 1-2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Condition 1: Peptic ulcer. Condition 2: Gastritis. Gastric ulcer -Duodenal ulcer - erosion (acute) of stomach -erosion (acute) of duodenum Chronic gastritis, unspecified , Acute (erosive) gastritis with haemorrhage;K25-K26;Gastric ulcer… |
| Interventions | Intervention 1: Group I (n=150) will receive quadruple therapy (20 mg omperazole bid, 240 mg bismuth subcitrate bid, 1000 mg tetracycline bid and 500 mg metronidazole bid) for 14 days. Intervention 2: Group II (n=150) will receive… |
| Registration date | Aug 13, 2011 |
| Target size | 300 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: